THURSDAY, MAY 25, 2017

University of Pittsburgh receives grants for HIV cure

Husband-and-wife research team receives $6.3 million in NIH grants. Read More »

Flu vaccine for elderly on track to approval

NVS Influenza Vaccines said Tuesday its candidate vaccine for those 65 and older to protect against seasonal influenza is currently under review by the U.S. Food and Drug Administration (FDA). Read More »

Study shows Ebola mutations can evade antibiotic treatments

The deadly Ebola virus has genetic mutations, or “escape variants,” that evade antibody-based treatments designed to fight infection. Read More »

BiondVax plans Phase 2 test of pandemic primer vaccine

BiondVax Pharma recently announced that the National Institute of Allergy and Infectious Diseases (NIAID), which is a branch of the National Institutes of Health, has planned the launch of a Phase 2 trial of Multimeric-001 (M-001) in the U.S. Read More »

NIH funds research for combining genomic information, electronic records

Researchers have received award grants from the National Institutes of Health (NIH) to find ways to combine genomic information with electronic medical records. Read More »

Vaxart works to advance oral tablet vaccines

Vaxart Inc. is creating a broad range of vaccines that are designed to be taken orally in tablet form rather than by a needle. Read More »

Single dose of cholera vaccine may interrupt epidemic

Researchers recently conducted a study that suggests a single dose of a cholera vaccine may provide people with adequate protection to stop the progress of the cholera epidemic. Read More »

National disease institute begins human RSV study

The National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health (NIH), recently began a new study to help them better understand the development of respiratory syncytial virus (RSV) infections in adults. Read More »

Wastewater a possible exposure route for Ebola

Researchers find virus survives in wastewater longer than previously thought. Read More »

Clinical trials for H1N1 influenza vaccine show promise

Vaxart Inc., a clinical-stage, privately held company that creates vaccines that are given to patients in the form of tablets instead of injections, recently announced that it has received positive results from its Phase 1 clinical trial of its oral H1N1 influenza vaccine. Read More »

MERS vaccine successful with camels, monkeys

Scientists from University of Pennsylvania and their colleagues recently announced that they have had positive test results when administering an experimental MERS-CoV vaccine to both camels and monkeys. Read More »

Epstein-Barr virus vaccine successful in animal testing

Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health (NIH), recently created a vaccine for Epstein-Barr virus (EBV) that has proven successful in mice as well as nonhuman primates. Read More »

First human West Nile virus case of 2015 confirmed in Maryland

The Department of Health and Mental Hygiene (DHMH) recently announced that it has confirmed Maryland’s first human West Nile virus case for the year 2015. Read More »

Researchers create largest genomic data set for Lassa virus

A team of researchers from around the world have created the biggest genomic data set for Lassa virus (LASV) in the world. Read More »

Epstein-Barr virus vaccine shows promise in animal study

A team of scientists from the National Institute of Allergy and Infectious Diseases, a branch of the National Institutes of Health, have created an experimental, nanoparticle-based vaccine for Epstein-Barr virus (EBV) that has successfully provoked potent neutralizing antibodies in mice and nonhuman primates. Read More »

Many youth with HIV may be susceptible to measles, mumps and rubella

The National Institutes of Health recently collaborated with the Centers for Disease Control and Prevention to report that the majority of youth who have HIV infections may have inadequate immunity against measles, mumps and rubella despite receiving vaccinations. Read More »

Heart risk may increase with hepatitis C infections

New research from Johns Hopkins suggests that people with hepatitis C virus infections have an increased risk for heart trouble. Read More »

Research furthers development of test for oral and genital herpes

Scientists at the National Institutes of Health (NIH), Johns Hopkins and Harvard universities have discovered some new research that could advance creating a universally accurate diagnostic test for the human herpes simplex viruses (HSV). Read More »

Scientists seek to improve flu vaccine

Scientists from Johns Hopkins Bloomberg School of Public Health recently reported that they have created a method that would make the nasal spray flu vaccine more effective for people both under two years old and over 49 years old. Read More »

Study shows Ebola vaccine to be safe and effective

Scientists from the National Institutes of Health recently reported that they have conducted a study that shows that a single dose of EBOV, an experimental Ebola vaccine, protects people against the Ebola strain that caused the outbreak in West Africa. Read More »